Nadimpalli, Gita;
O’Hara, Lyndsay M.;
Magder, Laurence S.;
Johnson, J. Kristie;
Haririan, Abdolreza;
Pineles, Lisa;
Goodman, Katherine E.;
Baghdadi, Jonathan D.;
Pineles, Beth L.;
Harris, Anthony D.
Comorbidities associated with 30-day readmission following index coronavirus disease 2019 (COVID-19) hospitalization: A retrospective cohort study of 331,136 patients in the United States
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Comorbidities associated with 30-day readmission following index coronavirus disease 2019 (COVID-19) hospitalization: A retrospective cohort study of 331,136 patients in the United States
Contributor:
Nadimpalli, Gita;
O’Hara, Lyndsay M.;
Magder, Laurence S.;
Johnson, J. Kristie;
Haririan, Abdolreza;
Pineles, Lisa;
Goodman, Katherine E.;
Baghdadi, Jonathan D.;
Pineles, Beth L.;
Harris, Anthony D.
imprint:
Cambridge University Press (CUP), 2023
Published in:Infection Control & Hospital Epidemiology
Description:
<jats:title>Abstract</jats:title><jats:sec id="S0899823X2200232X_as1"><jats:title>Objective:</jats:title><jats:p>Hospital readmission is unsettling to patients and caregivers, costly to the healthcare system, and may leave patients at additional risk for hospital-acquired infections and other complications. We evaluated the association between comorbidities present during index coronavirus disease 2019 (COVID-19) hospitalization and the risk of 30-day readmission.</jats:p></jats:sec><jats:sec id="S0899823X2200232X_as2"><jats:title>Design, setting, and participants:</jats:title><jats:p>We used the Premier Healthcare database to perform a retrospective cohort study of COVID-19 hospitalized patients discharged between April 2020 and March 2021 who were followed for 30 days after discharge to capture readmission to the same hospital.</jats:p></jats:sec><jats:sec id="S0899823X2200232X_as3"><jats:title>Results:</jats:title><jats:p>Among the 331,136 unique patients in the index cohort, 36,827 (11.1%) had at least 1 all-cause readmission within 30 days. Of the readmitted patients, 11,382 (3.4%) were readmitted with COVID-19 as the primary diagnosis. In the multivariable model adjusted for demographics, hospital characteristics, coexisting comorbidities, and COVID-19 severity, each additional comorbidity category was associated with an 18% increase in the odds of all-cause readmission (adjusted odds ratio [aOR], 1.18; 95% confidence interval [CI], 1.17–1.19) and a 10% increase in the odds of readmission with COVID-19 as the primary readmission diagnosis (aOR, 1.10; 95% CI, 1.09–1.11). Lymphoma (aOR, 1.86; 95% CI, 1.58–2.19), renal failure (aOR, 1.32; 95% CI, 1.25–1.40), and chronic lung disease (aOR, 1.29; 95% CI, 1.24–1.34) were most associated with readmission for COVID-19.</jats:p></jats:sec><jats:sec id="S0899823X2200232X_as4"><jats:title>Conclusions:</jats:title><jats:p>Readmission within 30 days was common among COVID-19 survivors. A better understanding of comorbidities associated with readmission will aid hospital care teams in improving postdischarge care. Additionally, it will assist hospital epidemiologists and quality administrators in planning resources, allocating staff, and managing bed-flow issues to improve patient care and safety.</jats:p></jats:sec>